Oslo, Norway, 4 September 2018
Reference is made to the release of the second quarter 2018 results on 30 August 2018 for Vistin Pharma ASA. Please find attached the investor presentation held today at Carnegie in connection with the results for the second quarter. The report will also be made available on www.vistin.com.
For further information, please contact:
Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com
Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachment